IDEXX Laboratories, Inc. IDXX has unveiled the IDEXX Cancer Dx, a first-of-its-kind diagnostic panel with early detection of lymphoma in dogs. This affordable and accessible blood test can be added to ...

This appointment is based on a press release statement and reflects Phibro's commitment to enhancing its governance and ...

The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the appointment of Joyce J. Lee, MBA, as a Class II director of the Company, effective immediately. Ms. Lee ...

Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its second quarter financial results on Wednesday, February 5, 2025, after the market closes. Phibro management will host a ...

The global Veterinary Vaccines Market, valued at US$8.93 billion in 2023, is forecasted to grow at a robust CAGR of 6.1%, reaching US$9.39 billion in 2024 and an impressive US$13.33 billion by 2029.

Veterinary Pharmaceutical Drug Market Expected To Achieve A Strong 5.07% CAGR, To Reach USD 40.3 Billion By 2032 The rising trend of pet ownership across various regions has significantly impacted the ...

The Global Glycolic Acid Market Size is projected to grow at a CAGR of 5.73% from 2024 to 2031, according to a new report published by Verified Market Research®. The report reveals that the market was ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Research analysts at Zacks Research raised their Q2 2025 EPS estimates for Phibro Animal Health in a report released on ...

The global veterinary biologics market is projected to grow from USD 13,140.6 million in 2024 to USD 24,224.3 million by 2034 ...

Jan. 15, 2025 — Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. ... New Innovative Local Treatment ...